Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Times Interest Earned (2018 - 2025)

Historic Times Interest Earned for Serina Therapeutics (SER) over the last 7 years, with Q3 2025 value amounting to -$1065.3.

  • Serina Therapeutics' Times Interest Earned fell 22088.35% to -$1065.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$730.12, marking a year-over-year decrease of 434249.09%. This contributed to the annual value of -$32.41 for FY2024, which is 47798.47% down from last year.
  • Per Serina Therapeutics' latest filing, its Times Interest Earned stood at -$1065.3 for Q3 2025, which was down 22088.35% from -$618.33 recorded in Q2 2025.
  • Serina Therapeutics' 5-year Times Interest Earned high stood at $1.37 for Q4 2023, and its period low was -$1065.3 during Q3 2025.
  • Moreover, its 5-year median value for Times Interest Earned was -$9.97 (2023), whereas its average is -$151.34.
  • Its Times Interest Earned has fluctuated over the past 5 years, first skyrocketed by 17515.11% in 2023, then crashed by 2393753.97% in 2024.
  • Quarter analysis of 5 years shows Serina Therapeutics' Times Interest Earned stood at -$6.33 in 2021, then soared by 71.21% to -$1.82 in 2022, then surged by 175.15% to $1.37 in 2023, then plummeted by 23937.54% to -$326.41 in 2024, then tumbled by 226.38% to -$1065.3 in 2025.
  • Its Times Interest Earned stands at -$1065.3 for Q3 2025, versus -$618.33 for Q2 2025 and -$326.41 for Q4 2024.